Feedback
AUROPHARMA 
Reputation: 642,681 • Jul 5, 2023 3:33 PM
Aurobindo Pharma gains on positive Phase-3 results of breast cancer drug
This phase 3 study is a multi-centre, randomized, double-blinded study involving females with metastatic HER2- positive breast cancer, company said.
Moneycontrol
Vote
Comment
Share
NSE:AUROPHARMA price when posted: 723.5